SCHEMBL4603250

SCHEMBL4603250

CCCN(C(=O)O)S(=O)(=O)NCCc1cccc(-c2ccc(OCCOC)cc2Oc2ncc(C(F)(F)F)cc2Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.53
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4603013 0.82 PPARG (0.53) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL4603253 0.81 PPARG (0.47) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL3216002 0.81 PPARG (0.63) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL3206552 0.79 PPARG (0.63) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL3216014 0.79 PPARG (0.67) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL3206547 0.79 PPARG (0.62) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL3211593 0.78 PPARG (0.70) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL3214131 0.78 PPARG (0.69) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL4524825 0.77 PPARG (0.61) PPARGALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL4602112 0.77 PPARG (0.62) PPARGALDH1A1LMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed